大塚ホールディングス is involved in the development and distribution of innovative pharmaceuticals, functional beverages, and functional foods.

大塚ホールディングス

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Apple Mobile Web Clips Icon

HSTS

Google Font API

DNSSEC

Global Site Tag

Font Awesome

Mobile Non Scaleable Content

Associate Director, Network and Communications

John Craig

Regional Director

Shawn Fairweather

Sr. Manager, Channel Strategy & Specialty Operations

Mark Kemp

Business Management

Saki Aoishi

Account Manager, Neuroscience Specialty- Injectable Sales

Anthony Quintana

Hospital Account Manager

David Mueller

Regulatory Affairs Associate

Maria Siquian

Medical Science Liaison

Mark Tacelosky

Nami Maru

Neuroscience Account Manager

Robert Mansdorf

Roch Doliveux

Debbie Profit

Vice President, OIT

Lisa Strouss

Director of Field Medical Digital Health

William Carson

Chief Executive Officer & President

Peter Zhang

Head of Biostatistics Department

Busaburo Otsuka

Founder

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

ReCor Medical has developed a unique therapeutic non-focused ultrasound system

Asia Public Companies With More Than $1M in Revenue (Top 10K)

Tokyo Public Companies With More Than $1M in Revenue

Tokyo Companies (Top 10K)

Manufacturing Public Companies (Top 10K)

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Tokyo

Japan

Asia

Otsuka Holdings

Duchenne Muscular Dystrophy (DMD) Therapeutics Market to Grow by USD 4.37 Billion from 2024-2028, Driven by High Unmet Needs and AI-Powered Market Evolution - Technavio

Otsuka Holdings says China's demand drives Pocari Sweat to new heights

Japan's Otsuka buys U.S. supplement maker Bonafide Health for $425m

US FDA approves Otsuka's blood pressure treatment device for use

LPAR2 antagonists reported in Otsuka Pharmaceutical patent

How AI Can Democratize Healthcare

Digital Therapeutics: The Basics

India

United States

North America

Indonesia

Singapore

HTML5

Amazon EC2

Office 365

Microsoft Outlook

jQuery

Google Analytics

Apache Server

Amazon Route 53

Google Maps API

Google Tag Manager

Otsuka Holdings owns Otsuka Pharmaceuticals

Otsuka Holdings owns Otsuka Medical Devices

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.

Otsuka Holdings Co., Ltd.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 23, 2024 4:57 AM	34cc539d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 23, 2024 4:57 AM	6dd10ca1
crunchbase trigger	general	Nov 27, 2024 12:50 PM	b3bb78c8
crunchbase profile	general	Nov 27, 2024 4:51 PM	3c9f341d
li profile	general
translate crunchbase fundingrounds	general	Nov 27, 2024 6:24 PM	d82974d7
peers	general	Oct 23, 2024 4:57 AM	4a695af1
news basic	general	Oct 23, 2024 4:57 AM	182c53fa
bundesanzeiger	filings
financials download nd	financials
private financials	financials

4578

COM:OTSUKA

大塚ホールディングス

Last Close

8,910.00

25/11 06:45

Market Cap

3.91T

Beta: -

Volume Today

3.20M

Avg: -